The report "Gene Expression Analysis Market by Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics) & Applications (Research, Drug Discovery, Diagnostic) - Global Forecasts to 2020", This report studies the global gene expression analysis market for the forecast period of 2015 to 2020. This market is expected to reach USD 5.30 Billion by 2020 from USD 3.39 Billion in 2015, at a CAGR of 9.3%.
Browse 96 market tables and 42 figures spread through 174 pages and in-depth TOC on "Gene Expression Analysis Market”
Early buyers will receive 10% customization on this report.
The global gene expression analysis market is a mature market that is expected to witness medium growth in the coming years. Factors such as availability of funding, growing number of cancer patients, strong focus on research, and decreasing cost of sequencing are driving growth in this market. However, the high cost of certain gene expression analysis instruments pose as a restraint for the market.
The development of gene therapy in the U.S., focus on gene expression studies to improve the quality of patient care, and the popularity of gene expression profiling tests are driving growth of the North American market. Growth in the Asia-Pacific region can be attributed to increasing research activities on agriculture, government intervention to improve healthcare, and rising popularity of gene expression tests.
Talk to Our Research Analysts for More Info@
On the basis of products and services, the gene expression analysis market is segmented into instruments, consumables, and services. The consumables segment dominates the gene expression analysis market in 2015. The large share of this segment can be attributed to the increasing number of gene expression analysis instrument installations worldwide, favorable funding scenario promoting research initiatives, and growing number of sequencing service centers that sequence huge volumes of data worldwide on a daily basis.
The services segment is expected to register the highest growth rate in the gene expression analysis market during the forecast period, 2015-20. Gene expression profiling is one of the major services in this market. The insights obtained through gene expression profiling plays a vital role in the advancement of disease diagnosis, drug discovery, and precision medicine. This is expected to boost the demand for gene expression profiling services in the coming years. In addition, institutes that face limitations such as budget constraints and dearth of skilled professionals carry out their research activities with the help of sequencing service providers; this is a major factor supporting the growth of the gene expression profiling services segment. This trend is likely to continue in the coming years.
Get The Sample Copy Of This Report:
The North America dominates the global expression analysis market. Europe represents the second largest market, followed by Asia-Pacific and Rest of World that comprises of Latin America, the Middle East, and Africa. The Asia-Pacific market is expected to register the highest growth for the forecast period 2015-20. The high growth in this region can be attributed to the respective regional government’s focus on cancer treatment, need to develop treatments for animals, gene expression tests gaining popularity and strong focus on neurodegenerative diseases.
Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), and PerkinElmer (U.S.) are some of the major players in gene expression analysis market.
Browse Related Reports:
Next Generation Sequencing (NGS) Market by Platforms (Illumina HiSeq, MiSeq, HiSeqX Ten, NextSeq 500,Thermo Fisher Ion Proton/PGM), Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT) & by Application (Diagnostics, Personalized Medicine) - Global Forecast to 2020.
European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020.
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets